CTA-Sticky-button.png clinicaltrialsyearbook+button

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player


Immuno-Oncology Trials

Immuno-oncology is a revolution in cancer research world that is transforming the way that treatments are planned and performed. This article tries to outline the opportunities and challenges that may arise in immuno-oncology trials, as more pharma and bio-technological companies are implementing it.

First of all, we need to understand the importance of immuno-oncology trials. Over last three decades, research has been proactively supporting theory that tumours are acknowledged by the immune system, and most importantly, that their development can be prevented and controlled over a long term.

Due to positive research towards immuno-oncology, more and more companies in the industry are keen to implement it in their trials. The biggest opportunity that everyone is chasing is the potential for immuno-oncology to completely transform the treatment of cancer. And even though the cost of employing such strategies is extremely high, cancer research could benefit massively making related oncology companies leaders in the industry.

There are many challenges in immuno-oncology, with regulatory obstacles being one of them. Ironically, one of the biggest inconveniences within immuno-oncology regulations is that there are very little regulations so far, due to the novelty of this type of research. Without any clear regulations to follow, problems like projecting accurate timeframe or calculating budget might arise.

During the Clinical Operations in Oncology Trials West Coast 2017 conference, we will be addressing this problem. On the day two we have Jamie Cross, Senior Director, Regulatory Affairs at Forty Seven delivering a topic on overcoming regulatory challenges unique to the conduct of immuno-oncology trials. Not only he will be outlining the difficulties, but also consulting the audience and highlighting the most important aspects of immuno-oncology regulations.

If you want to hear more insight into immuno-oncology trials and see a full picture of operations in oncology, we highly recommend booking a ticket to our annual Clinical Operations in Oncology Trials West Coast 2017 conference. Taking place in April in Burlingame, South San Francisco, California, this conference promises an amazing speaker line up and exciting panel discussions.

You can reserve your place in the conference here

Countdown to Clinical Operations in Oncology Trials West Coast 2018